Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama shares closed near C$204.69 on December 24, 2025, as the S&P/TSX approached record highs in a shortened holiday session. The stock hit fresh highs after reporting Q3 sales up 22.2% to $1.91 billion and net earnings up 16.6% to $321.7 million. Investors are debating whether its premium valuation is justified as the company expands beyond its core market.
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals shares fell to $0.32 on December 24, 2025, after the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine before a New Drug Application. The company said the new trial, RECOVER-2, could cost $60 million and delay potential approval to late 2028. Reviva plans to start the trial in the first half of 2026, pending financing.
Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Regencell Bioscience Holdings (RGC) surged 14% to $25.25 on Dec. 24, 2025, despite remaining a pre-revenue company. The move followed a ValueWalk article highlighting RGC’s 17,000% gain in 2025, driven by low float, momentum trading, and a recent 38-for-1 stock split. Intraday prices ranged from $22.00 to $26.33. RGC’s market cap neared $11 billion.
Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

The S&P 500 closed at a record 6,909.79 Tuesday, while U.S. stock futures edged lower early Wednesday ahead of a holiday-shortened session. A strong third-quarter GDP reading at 4.3% and persistent inflation are clouding the outlook for Federal Reserve rate cuts in 2026. The NYSE will close at 1 p.m. ET, with U.S. markets shut Thursday for Christmas. Key government data releases were delayed by a federal shutdown.
24 December 2025
Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics announced a $6 million preferred-stock financing with investor David Lazar, who will become chairman and co-CEO. The deal could add up to 111 million common shares if converted, pending shareholder approval. Shares jumped over 60% after hours on December 23, 2025, following the news, after closing at $1.95 in regular trading. Two directors resigned as part of the boardroom changes.
Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next

Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next

Churchill Capital Corp X (NASDAQ: CCCX) surged nearly 10% to $17.27 on Dec. 23, 2025, and traded above $18 pre-market after Infleqtion’s chief scientist won the John Stewart Bell Prize. The rally is linked to renewed momentum around CCCX’s planned merger with Infleqtion, a quantum technology firm. CCCX remains a SPAC, with trading driven by sentiment and headlines.
Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands shares traded near $10.53 on December 24, 2025, following sharp gains in the second half of the year. President Donald Trump signed an executive order on December 18 to begin the process of reclassifying marijuana from Schedule I to Schedule III. The move sparked volatility across cannabis stocks, with prices swinging as investors weighed the potential impact. The order does not legalize cannabis but directs federal agencies to review its status.
Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

The U.S. Pipeline and Hazardous Materials Safety Administration approved Sable Offshore Corp.’s plan to restart the Las Flores Pipeline System in California, according to a December 22 letter disclosed in an SEC filing. SOC shares surged 36% to $10.36 on December 23 and held those gains in early trading December 24. The pipelines, formerly Plains Line 901 and 903, have been at the center of a years-long dispute.
24 December 2025
Northann Corp Stock (NCL) Slumps After “News Pending” Halt as Dilution, Reverse Split Vote and NYSE Compliance Deadlines Loom

Northann Corp Stock (NCL) Slumps After “News Pending” Halt as Dilution, Reverse Split Vote and NYSE Compliance Deadlines Loom

Northann Corp. (NCL) shares fell 33% to $0.17 on December 23 before a NYSE American “news pending” trading halt, then rebounded in pre-market trading. The company disclosed two new advisory agreements to be paid in stock, totaling 3.3 million shares, pending exchange approval. Investors remain focused on dilution risk and listing compliance.
24 December 2025
Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Sanofi announced a deal to acquire Dynavax Technologies for $2.2 billion in cash, offering $15.50 per share—a 39% premium to Dynavax’s prior close. DVAX stock jumped about 37% premarket to near the offer price. Dynavax’s board approved the transaction. Closing is expected in Q1 2026, pending regulatory and shareholder approvals.
BP Stock Jumps on $6 Billion Castrol Stake Sale: What It Means for BP Shares, Debt, Dividends, and 2026 Outlook (Dec. 24, 2025)

BP Stock Jumps on $6 Billion Castrol Stake Sale: What It Means for BP Shares, Debt, Dividends, and 2026 Outlook (Dec. 24, 2025)

London/New York — December 24, 2025 — BP p.l.c. (NYSE: BP; LSE: BP.) is back in the spotlight on Christmas Eve after agreeing to sell a controlling 65% stake in its Castrol lubricants business to U.S. investment firm Stonepeak, a deal BP says values Castrol at $10.1 billion and will deliver roughly $6 billion of net proceeds to the oil major. The market’s initial reaction was positive-but-measured: BP shares rose more than 1% shortly after the announcement before trading turned choppy in thin, holiday-shortened conditions. Reuters+1 For investors, this is one of those corporate moves that reads like a clean
24 December 2025
Multi Ways Holdings Limited (MWG) Stock Jumps on H1 2025 Results: Revenue Up 88%, Profit Improves, and 2026 Infrastructure Outlook in Focus (Dec. 24, 2025)

Multi Ways Holdings Limited (MWG) Stock Jumps on H1 2025 Results: Revenue Up 88%, Profit Improves, and 2026 Infrastructure Outlook in Focus (Dec. 24, 2025)

Multi Ways Holdings shares jumped about 60% in pre-market trading on December 24 after the Singapore-based company reported first-half 2025 revenue of $26.44 million, up 88% year-over-year. Net income rose to $0.90 million from $0.08 million. Gross margin fell to 25.08% from 33.07% as sales mix shifted. Management cited strong equipment demand and infrastructure activity.
24 December 2025
International Flag-State Association seeks IMO consultative status

International Flag-State Association seeks IMO consultative status

Liberia, the Marshall Islands, and Panama are preparing to apply for consultative status at the International Maritime Organization through their joint platform, the International Flag-State Association. The registries say they represent over 40% of global shipping tonnage. The IFA, formed in 2021, aims to give flag States a more direct role in shaping maritime policy.
24 December 2025
First Solar Stock (FSLR) Swings After Alphabet-Intersect Deal: Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

First Solar Stock (FSLR) Swings After Alphabet-Intersect Deal: Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

First Solar shares hit an intraday high near $285.99 on Dec. 22, then dropped 5.3% to $269.39 on Dec. 23 amid volatile trading. The move followed Alphabet’s $4.75 billion deal to acquire Intersect, a company tied to First Solar through a 2.4 GW module supply agreement. Thin holiday trading volumes contributed to sharp price swings.
NIKE Stock (NKE) News on Dec. 24, 2025: Tim Cook Buys $3M in Shares as Analysts Debate Nike’s 2026 Turnaround

NIKE Stock (NKE) News on Dec. 24, 2025: Tim Cook Buys $3M in Shares as Analysts Debate Nike’s 2026 Turnaround

Nike shares rose about 2% in premarket trading Dec. 24 after Apple CEO and Nike director Tim Cook bought 50,000 shares at $58.97, SEC filings show. Director Robert Swan also purchased 8,691 shares at $57.54. The moves follow a 13% post-earnings drop after Nike reported Q2 net income down 32% and gross margin hit by tariffs. Nike stock last traded near $57.34.
24 December 2025
Moderna Stock (MRNA) Today: Shares Cool Off After a Late-December Spike as Investors Focus on Bird Flu Funding, mNEXSPIKE’s EU Path, and 2026 Growth Targets

Moderna Stock (MRNA) Today: Shares Cool Off After a Late-December Spike as Investors Focus on Bird Flu Funding, mNEXSPIKE’s EU Path, and 2026 Growth Targets

Moderna shares fell 7.48% to $32.29 on Dec. 23 after a sharp rally earlier in the week. The drop followed news of up to $54.3 million in CEPI funding for its bird flu vaccine, with a Phase 3 trial set for early 2026. The stock’s volatility contrasted with broader market gains, as investors reacted to recent headlines and year-end trading dynamics.

Stock Market Today

Xero share price (ASX:XRO) ends lower as tech rout grinds on; what investors watch next week

Xero share price (ASX:XRO) ends lower as tech rout grinds on; what investors watch next week

8 February 2026
Xero closed Friday down 0.4% at A$81.76, near last week’s low, as software stocks slumped. The S&P/ASX 200 Tech Index was set to end the week down about 12%, hitting levels last seen in December 2023. Global tech shares also fell, with nearly $1 trillion in value erased from U.S. software stocks since Jan. 28. Investors await fresh rate and inflation signals next week.
Huntington Bank taps ex-BNY risk boss Senthil Kumar as new chief risk officer

Huntington Bank taps ex-BNY risk boss Senthil Kumar as new chief risk officer

8 February 2026
Huntington Bank named Senthil Kumar chief risk officer, effective Feb. 16, as it enters a stricter regulatory category after closing its Cadence Bank merger on Feb. 2. Kumar replaces Helga Houston, who becomes senior executive adviser March 1. The merger brings Huntington’s assets to about $279 billion, triggering tougher oversight. No branch closures are planned before a mid-2026 systems conversion.
Go toTop